Search

Your search keyword '"Stroka, Deborah"' showing total 366 results

Search Constraints

Start Over You searched for: Author "Stroka, Deborah" Remove constraint Author: "Stroka, Deborah"
366 results on '"Stroka, Deborah"'

Search Results

1. An optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno-associated virus vector compatible with biosafety level 1

3. Author Correction: Tumour mutations in long noncoding RNAs enhance cell fitness

4. Tumour mutations in long noncoding RNAs enhance cell fitness

7. ILC3s restrict the dissemination of intestinal bacteria to safeguard liver regeneration after surgery

10. Author response: Germline cis variant determines epigenetic regulation of the anti-cancer drug metabolism gene dihydropyrimidine dehydrogenase (DPYD)

11. Germline cis variant determines epigenetic regulation of the anti-cancer drug metabolism gene dihydropyrimidine dehydrogenase (DPYD)

16. Germlinecisvariant determines epigenetic regulation of the anti-cancer drug metabolism gene dihydropyrimidine dehydrogenase (DPYD)

24. Data from The Novel ATP-Competitive Inhibitor of the MET Hepatocyte Growth Factor Receptor EMD1214063 Displays Inhibitory Activity against Selected MET-Mutated Variants

27. Supplementary Figure and Table Legends from The Novel ATP-Competitive Inhibitor of the MET Hepatocyte Growth Factor Receptor EMD1214063 Displays Inhibitory Activity against Selected MET-Mutated Variants

29. Supplementary Figure 1 from The Novel ATP-Competitive Inhibitor of the MET Hepatocyte Growth Factor Receptor EMD1214063 Displays Inhibitory Activity against Selected MET-Mutated Variants

30. Supplementary Table 1 from The Novel ATP-Competitive Inhibitor of the MET Hepatocyte Growth Factor Receptor EMD1214063 Displays Inhibitory Activity against Selected MET-Mutated Variants

31. Supplementary Materials and Methods from The Novel ATP-Competitive Inhibitor of the MET Hepatocyte Growth Factor Receptor EMD1214063 Displays Inhibitory Activity against Selected MET-Mutated Variants

32. An optimized protocol for generating and monitoring conditional orthotopic lung cancer in the KP mouse model at BSL-1

36. Claudin-3-deficient C57BL/6J mice display intact brain barriers

38. Stimulatory MAIT cell antigens reach the circulation and are efficiently metabolised and presented by human liver cells

39. OMIP-088: Twenty-target imaging mass cytometry panel for major cell populations in mouse formalin fixed paraffin embedded liver

43. Primary Infection by E. multilocularis Induces Distinct Patterns of Cross Talk between Hepatic Natural Killer T Cells and Regulatory T Cells in Mice

46. Primary Infection by E. multilocularis Induces Distinct Patterns of Cross Talk between Hepatic Natural Killer T Cells and Regulatory T Cells in Mice

48. Splenic red pulp macrophages provide a niche for CML stem cells and induce therapy resistance

49. Primary Infection by E. multilocularis Induces Distinct Patterns of Cross Talk between Hepatic Natural Killer T Cells and Regulatory T Cells in Mice

50. Tumour mutations in long noncoding RNAs enhance cell fitness

Catalog

Books, media, physical & digital resources